Clinical Trial Update: Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effectiveness and safety of solifenacin succinate alone and with estrogen for overactive bladder in postmenopausal women has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Postmenopausal Syndrome

Drugs mentioned

• Solifenacin Succinate + Estrogen
• Solifenacin succinate (solifenacin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Overactive Bladder, Postmenopausal Disorder | Phase 4 | Status: COMPLETED